Go to CURRENT / COMPLETED Studies

Current Studies

PI: Nicholas DiPatrizio, PhD

This study will examine the impact of cannabis exposure on gut barrier function in metabolic disease and experimental colitis

PI: Doris Trauner, MD

This clinical trial is examining if and how cannabidiol (CBD), a chemical found in the cannabis plant, provides therapeutic benefit to children with severe autism spectrum disorder (ASD). The trial is funded by a grant from the Ray and Tye Noorda Foundation in partnership with and based on recommendations from the Wholistic Research and Education Foundation.

PI: Jeremy Pettus, MD

This study will seek to determine the effects of THC use on glucose metabolism

PI: Guido Frank, MD

Because there are no proven treatments that normalize core symptoms in adult anorexia nervosa (AN), a disorder with high chronicity and mortality, many individuals seek out alternative approaches to care.  Recent evidence has suggested that exaggerated anxiety and diminished reward or motivation to eat play a key role in causing AN symptoms and poor outcome. 

PI: Erin Morgan, PhD

This study will examine whether CBD will reduce alexithymia and inflammation in people with HIV

PI: Michael Taffe, PhD

This study will examine the effects of cannabis and cannabinoids on the behavioral and molecular outcomes of motivational and stress-mediated changes associated with prescription oxycodone addiction and dependence.

PI: Veena Ranganath, MD

The overall goal of this proof-of-principle proposal is to examine the efficacy and safety of CBD treatment as adjunctive to the medical management of Rheumatoid Arthritis (RA) patients with moderate to severe disease activity.

PI: Arpi Minassian, PhD

This study will utilize a cross-species approach to delineate the effects EC system activation has on HIV-relevant cognitive and motivational domains.